AGC Biologics
Americas
Bothell
,
United States
Multinational
FOUNDED
2018
HEADCOUNT
1001-5000
FUNDING
Subsidiary
Keywords:
CDMO, mammalian_cells, bacteria, therapeutics, antibodies, vaccines
BUSINESS
Global CDMO offering development and manufacturing services for protein-based biologics, cell and gene therapies, pDNA, mRNA, and viral vectors. Operates facilities across the US, Europe, and Asia.
BIOTECH INVOLVEMENT
Core; global CDMO offering process development and manufacturing for protein-based biologics, cell and gene therapies, plasmid DNA, mRNA, and viral vectors, with mammalian-cell and microbial fermentation operations across US, Europe, and Asia.
TECHNOLOGY PLATFORM
mammalian and microbial expression systems; transposase technology; AAV, LVV, RVV systems
PRIMARY PRODUCTS
CDMO services for therapeutic proteins; cell therapy; viral vectors; plasmid DNA; messenger RNA